The cost of Tymlos (abaloparatide) can vary significantly depending on insurance coverage, pharmacy, and whether it is purchased through a discount program. A 30-day supply of Tymlos, which typically includes one auto-injector pen and cartridges, can have a list price of approximately $6,000 to $7,000 before any discounts or insurance. [1]
What influences Tymlos pricing?
Several factors contribute to the final out-of-pocket cost for patients. These include the patient's specific insurance plan, which can dictate co-pays or co-insurance amounts. Manufacturer discount programs and patient assistance programs are also available and can substantially reduce the cost for eligible individuals. [1]
How can I get financial assistance for Tymlos?
For patients facing high costs, financial assistance options are available. Radius Pharmaceuticals, the maker of Tymlos, offers programs that can lower monthly costs. For instance, eligible commercially insured patients may pay as little as $0 for their monthly prescription through the Tymlos Savings Card program. [1]
How does Tymlos pricing compare to other osteoporosis treatments?
When compared to other osteoporosis medications, Tymlos is generally considered a high-cost therapy. However, its cost should be weighed against its efficacy and the potential for reducing fracture risk. The overall cost of managing osteoporosis, including hospitalizations and treatments for fractures, can also be substantial, which is a factor in assessing the value of medications like Tymlos.
When does Tymlos patent protection end?
Information regarding the specific patent expiry dates for Tymlos is available through specialized patent tracking services. DrugPatentWatch.com tracks patent information for numerous pharmaceutical products, including their expiry timelines. [2] Understanding patent expiry is crucial for anticipating the potential market entry of generic or biosimilar alternatives, which could impact pricing in the future.